Manel Juan Otero

Head of Immunotherapy Platform Hospital Clinic of Barcelona

Seminars

Wednesday 25th February 2026
Panel Discussion: Feasibility & Merits of Setting up Point of Care Manufacturing to Drive Patient Access & Reduce CGT Costs
2:00 pm
  • Evaluating the true feasibility and practicality of point-of-care manufacturing in today’s CGT landscape
  • Weigh upfront costs, staffing, and infrastructure requirements against potential long-term savings
  • Discussing whether the benefits of local access outweigh regulatory, operational, and scalability hurdles
Tuesday 24th February 2026
Leveraging Hospital Exemption & Compassionate Use to Improve Patient Access Under Evolving EU Legislations
1:30 pm
  • Discuss how hospital exemptions and compassionate use frameworks operate across Europe and their role in bridging access gaps
  • Highlight the implications of ongoing legislative reviews on developer responsibilities, regulatory oversight, and safety standards
Wednesday 25th February 2026
Industry Leaders Fireside Chat: Navigating Europe’s Cell Therapy Landscape Amid Investment Pressures, Novel Approaches, & Opportunities for Patient Access
8:30 am
  • Discuss how investment headwinds are shaping company strategies and what it takes to sustain progress in Europe
  • Highlight the most promising scientific advances, including novel indications, armouring strategies, and in-vivo approaches
  • Explore how patient access models, from point-of-care manufacturing to evolving reimbursement pathways, can unlock future growth
Manel Juan Otero